Iptacopan in Idiopathic Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Protocol of the APPARENT Multicenter, Randomized Phase 3 Study

Vivarelli, M., Bomback, A. S., Meier, M., Wang, Y., Webb, N. J. A., Veldandi, U. K., Smith, R. J. H., & Kavanagh, D. (2024). Iptacopan in Idiopathic Immune Complex–Mediated Membranoproliferative Glomerulonephritis: Protocol of the APPARENT Multicenter, Randomized Phase 3 Study. Kidney International Reports, 9(1), 64–72. https://doi.org/10.1016/j.ekir.2023.10.022
Authors:
Marina Vivarelli
Andrew S Bomback
Matthias Meier
Yaqin Wang
Nicholas J A Webb
Uday Kiran Veldandi
Richard J H Smith
David Kavanagh
Affiliated Authors:
Andrew S Bomback
Columbia Affiliation:
Author Keywords:
alternative complement pathway
glomerular filtration rate
ic-mpgn
idiopathic immune complex–mediated membranoproliferative glomerulonephritis
iptacopan
phase 3 study design
elink
Publication Type:
Article
Unique ID:
10.1016/j.ekir.2023.10.022
PMID:
38312795
DOI:
10.1016/j.ekir.2023.10.022
Journal:
Kidney International Reports
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: